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Mechanistic details of the membrane perforation and passive 
translocation of TAT peptides 
Stefania Piantavigna,[a] Muhammad E. Abdelhamid,[a,b] Chuan Zhao,[c] Xiaohu Qu,[a,d] George A. 
McCubbin,[a] Bim Graham,[e] Leone Spiccia,[a] Anthony P. O’Mullane,[f]* Lisandra L. Martin*[a] 
Abstract The TAT peptide is regarded as the ‘gold standard’ for cell-
penetrating peptides; capable of traversing a mammalian membrane 
passively into the cytosolic space. This characteristic has been 
exploited through conjugation of TAT for applications, such as drug 
delivery. However, the process by which TAT achieves membrane 
penetration remains ambiguous and unresolved. Mechanistic details 
of TAT peptide action are revealed here using three complementary 
methods; quartz crystal microbalance with dissipation (QCM-D), 
scanning electrochemical microscopy (SECM) and atomic force 
microscopy (AFM). Combined these three scales of measurement, 
define that the membrane uptake of the TAT peptide is by trans-
membrane insertion using a 'worm-hole' pore that leads to ion 
permeability across the membrane layer. AFM data provided 
nanometre-scale visualisation of TAT punctuation using a 
mammalian-mimetic membrane bilayer. The TAT peptide does not 
show the same specificity towards a bacterial mimetic membrane 
and QCM-D and SECM showed that the TAT peptide demonstrates 
a disruptive action towards these membranes. This investigation 
supports the energy-independent uptake of the cationic TAT peptide 
and provides empirical data that clarifies the mechanism by which 
the TAT peptide achieves its membrane activity. The novel use of 
these three biophysical techniques provides valuable insight into the 
mechanism for TAT peptide translocation which is essential for 
improvements in the cellular delivery of TAT-conjugated cargoes 
including therapeutic agents required to target specific intracellular 
locations. 
Introduction 
The cell membrane constitutes an efficient barrier that is 
impermeable to hydrophilic molecules. As a consequence, the 
internalisation of therapeutic agents can be difficult to achieve. 
The human immunodeficiency virus type 1 (HIV-1) uses a 
nuclear transcription-activating protein, TAT, that has the ability 
to translocate across the mammalian cell membrane[1] and 
carry conjugated molecules to intracellular locations.[2] There is 
enormous interest in revealing the molecular basis of the 
translocation of TAT, as an extensive range of biomolecules 
can be conjugated to the TAT peptide and this cargo delivered 
to an intracellular location. Application to the intracellular 
delivery of drugs and therapeutics through modification with 
such membrane translocation sequences, especially using 
TAT peptides, was immediately recognized (see review by 
Fisher, 2005) and the exploration of cell-penetrating peptides 
(CPPs) is now a well established field.[3] Thus this knowledge 
will enable the next generation of pharmaceuticals to reach 
site-specific targets and more effective drug delivery to be 
achieved. 
Cellular localisation studies using fluorescent conjugates 
with the TAT (37-60) peptide have revealed two distinct 
membrane active motifs:[4] The TAT (38-49) region, which 
adopts an α-helical, amphipathic secondary structure and a 
highly cationic, basic domain, TAT (49-58). Remarkably, the 
basic region, GRKKRRQRRRQ (TAT (49-58)), is responsible 
for membrane translocation through the plasma membrane.[4] 
Cell-penetrating and tumor-targeting peptides that specifically 
target and kill cancerous cells by exploiting the 
microenvironment of specific tumors are the future alternatives 
to small molecule-based chemotherapeutics.[5]  
A large number of peptides are now recognised as being 
capable of crossing cellular membranes using a variety of 
mechanisms. Members of the CPP family include TAT and 
penetratin peptides, which are arginine-rich[6] and proline-rich 
apidaecin and oncocin peptides[7] as well as many others.[8] 
Over the past decade there has been intense debate as to the 
mechanism of action of CPPs. Several models are used to 
describe how membrane-active peptides interact with 
biomembranes (biomimetic and plasma membranes). The 
most common interactions are classically described as either 
pore formation (either barrel-stave or toroidal pores) or carpet-
like membrane disruption.[5, 8a, 9] However, despite numerous 
investigations, using a wide range of approaches to investigate 
the TAT peptide membrane translocation process there 
remains much ambiguity and uncertainty regarding the precise 
mechanism for cellular internalisation of the TAT peptide.  
Both non-endocytotic and endocytotic (clathrin-dependent, 
caveolae-dependent, clathrin- and caveolae independent 
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and/or macropinocytosis) pathways have been suggested with 
proponents of the former differing in their views as to whether 
the TAT translocation occurs via pore, carpet or inverted 
micelle formation.[6, 10] The current view predominantly favours 
endocytosis for TAT uptake by cells, although substantial 
evidence exists for direct translocation (via pore formation)[11] 
occurring in an energy-independent, non-receptor mediated 
manner. 
Biophysical studies using supported lipid bilayers (SLB) 
eliminate endocytosis mechanisms, however they still do not 
provide unequivocal clarification of the membrane activity of 
the TAT peptide. Previously, we demonstrated that TAT’s 
activity is dependent on membrane composition, with the 
presence of 20% negatively charged lipid in the membrane 
leading to rapid disruption via a surface-active ‘carpet’ 
mechanism.[7d] However, a neutral ‘mammalian’ biomimetic 
membrane containing phosphatidylcholine and cholesterol 
showed no disruption, suggesting roles for both electrostatic 
and hydrophobic interactions of the TAT peptide with 
membranes[7d]. Using neutron and X-ray reflectivity 
measurements, Choi[12] concluded that the TAT peptide formed 
membrane defects rather than pores in phosphatidylcholine-
containing membranes. Recently, Bradshaw used neutron 
diffraction to demonstrate that TAT bound to both the surface 
lipid ‘head-groups’ and in the ‘tail-groups’ binding to the 
glycerol backbone in the lipid layer and associated with water 
channels.[13] Using giant unilaminar liposomes (GUVs) and 
single-molecule fluorescence, Ciobanasu et al.[14] showed that 
diffusion mobility of the TAT peptide was independent of 
membrane phase (liquid-ordered or liquid-disordered) and that 
the peptides ‘float’ on the lipid layers rather than incorporate 
into membranes containing neutral lipids. Interestingly, they 
subsequently reported evidence for pore formation.[15] In silico 
mechanistic studies employing molecular dynamics also 
support translocation via a pore.[16] Recently, Lattig-
Tünnemann et al.[17] combined molecular dynamics, analytical 
ultracentrifugation and cellular microscopy to demonstrate 
improved membrane translocation for a cyclic TAT peptide, 
suggesting that positional fixation of the guanidinium groups of 
the arginine residues leads to more efficient occupation of the 
membrane surface. They concluded that the spatial orientation 
of the arginines and structural rigidity were the driving factors 
for membrane translocation and importantly, that no ‘needle-
like’ structures were required for uptake.[17] Taken together, 
each of these studies provide indications, however the 
mechanistic details as to how TAT and other cationic and 
hydrophilic peptides translocate directly through the 
hydrophobic core of the lipid membrane remains elusive. 
Here we report the membrane activity of two TAT peptides, 
TAT (44-57) and TAT (49-57), derived from the amino acid 
sequence Ac-GI45SYGRK50KRRQR55RR-NH2, towards neutral 
phosphatidylcholine containing cholesterol (PCc), i.e. 
mammalian mimetic and phosphatidylcholine with 
phosphatidylglycerol (PC:PG, 2:1); i.e. bacterial mimetic 
membrane. We have previously shown membrane composition 
influences these interactions for the TAT peptide(s) acting via 
both electrostatic and hydrophobic interactions towards 
biomimetic membranes.[7d] Specifically, here we have extended 
the investigation of the two TAT peptides using three scales of 
measurement: (i) monitoring the binding and structural 
changes using a quartz crystal microbalance (QCM), (ii) 
measurement of the permeability of the TAT-treated 
membranes towards ionic conductance using scanning 
electrochemical microscopy (SECM) and (iii) high resolution 
structural investigation of membrane morphology following 
addition of TAT using atomic force microscopy (AFM).  
The experimental design for the QCM and SECM 
measurements is illustrated in Figure 1a. This illustration 
shows how the membrane-coated sensors were used for both 
QCM and SECM measurements. Thus complementary 
biophysical techniques enabled the TAT peptide biomimetic 
lipid bilayer interaction to be investigated at the millimetre, 
micrometre and nanometre scales with concentration-
dependent with spatial and temporally resolved measurements 
made in solution under pseudo-physiological conditions.  
 
Figure 1. The experimental design for the SECM and QCM experiments. 
Panel a) LHS: before addition of TAT, the QCM shows the intact lipid bilayer 
and the SECM shows an insulating membrane layer, in which a redox 
mediator, converted to the oxidized form (O) by an ultramicroelectrode 
(UME), is unable to be reduced back to the reduced form by the underlying 
gold electrode (negative feedback mode); see also b(iii). RHS: after addition 
of TAT, the QCM responds with a decrease in frequency as the TAT binds to 
the membrane and a concomitant change in dissipation due to the effect of 
TAT on the membrane viscoelasticity. SECM will now respond if a pore-like 
structure is formed in which the redox mediator can be regenerated (positive 
feedback mode); see also b(ii). Panel b) approach curves for a conducting 
(ii) and insulating (iii) material are indicated.  If an insulating material 
(membrane) is compromised to allow access of a solution-based mediator to 
the underlying conductor (gold), an approach curve that is intermediate 
between the presented extremes will be expected to be recorded. 
Results and Discussion 
QCM study of TAT binding to membranes. QCM measures 
changes in the harmonic frequency (f) of an oscillating sensor 
as mass is added.[18] The QCM-D[19] instrument simultaneously 
measures the energy loss to the surrounding environment, or 
dissipation factor (D), thus providing an assessment of the 
viscoelasticity of the resulting peptide-membrane layer.[20] 
Additional information about mass and structure are obtained 
using the different harmonics of the QCM sensor, providing a 
depth-profile orthogonal to the sensor surface.[21] The 
penetration depth of each harmonic wave adjacent to the 
sensor is inversely proportional to the frequency.[22] Thus, a 
surface-active peptide will influence the third more than the 
ninth harmonic, whereas a peptide that traverses the 
membrane bilayer will affect all of the harmonics similarly. 
Biomimetic membranes, formed by liposome deposition[23] 
and composed of either 7:3 DMPC:cholesterol (‘PCc’ 
eukaryotic or mammalian mimetic) or 2:1 DMPC:DMPG 
(‘PC:PG’ bacterial or prokaryotic mimetic) bilayers, were used 
to examine the effect of the TAT peptides. The change in 
frequency (Δf) and energy dissipation (ΔD) over time (Fig. S1) 
comprise the raw data acquired following the introduction of 
the TAT peptides into the QCM-D chamber.  These data were 
          
analysed and presented as Δf-ΔD plots that represent the 
structural change(s) that occur as the TAT interacts with the 
membrane (per unit frequency or mass), as described 
previously.[20] Introduction of TAT (44-57) to the membrane 
layers yielded the Δf-ΔD plots in Figure 2 for 1.0 and 10 µM 
TAT (44-57). Similar Δf-ΔD plots for TAT (49-57) are shown in 
Figure S2. For the DMPC:DMPG membrane layer, the 
interaction of the TAT occurs via a two-stage mechanism 
(Figure 2a), consistent with our previous reports.[7d] The initial 
binding of the peptide (from the origin in a negative direction) is 
followed by a loss of mass (f shifts in a positive direction). At 
higher concentrations (10 µM), the binding phase is less 
prominent but is followed by the same loss of mass (i.e. Δf 
positive). 
 
Figure 2. QCM data analysed using ΔD vs. Δf profiles examining the 
effects of the TAT (44-57) peptide interaction on the sensors with 
bacterial (PC:PG) and mammalian (PCc) mimetic membranes.  ΔD vs. Δf 
profiles examining the effect on the sensor harmonics as the TAT peptide (at 
two different peptide concentrations) interacts with the lipid bilayers 
previously deposited. In each case, the peptide inserts in a trans-membrane 
manner, discerned by all the harmonics overlapping. No difference is 
observed between the two concentrations studied. However, for the PC:PG 
membrane a dramatic effect is observed upon introduction of the TAT (44-
57) peptide, with a huge mass loss (Δf increases) and simultaneous 
dramatic decrease in viscoelasticity (ΔD decreases) occurring. This is 
consistent with membrane disruption. 
The QCM-D results for mammalian-mimetic (PCc) 
membrane (Figure 2b) interestingly shows no change in 
dissipation (ΔD ~ 0) as the TAT peptide binds (Δf ~5 Hz) the 
bacterial-mimetic (PC:PG) membrane. Figure 2b, also shows 
no removal of mass is observed, ruling out the occurrence of 
carpet disruption, inverted micelle formation or endocytosis 
under our experimental conditions. Similar data were observed 
for TAT (49-57) and at higher concentrations (10 µM) (Figure 
S2). We previously reported this QCM-D behaviour as 
consistent with either pore formation or direct translocation, as 
all would result in the observed mass increase.[7d] Pore 
formation is considered more likely, as the overlap of the 
response of the harmonic frequencies in the Δf-ΔD plot 
suggests that the peptides insert into the membrane in a trans-
membrane manner (Figure 2b).[21] However, QCM-D data 
alone is insufficient to conclusively distinguish between these 
three mechanisms. 
 
SECM study of membrane permeability to redox 
mediators. SECM is an ideal tool to characterize the 
permeability of self-assembled monolayers, lipid membranes 
and biological systems at the micrometer scale and has found 
increasing biological applications in recent years.[24] After the 
QCM-D experiments, the sensor crystals were carefully 
removed from the chambers and the permeability of the 
peptide-membrane layers was measured using the ‘approach 
curve’ method (see Figure 1b). In this manner, the SECM 
results could be directly correlated with the QCM-D data. 
Figure 3 presents normalized approach curves obtained for the 
sensor crystal and various adlayers: 6-mercaptohexanoic acid 
(MHA) self-assembled monolayer; MHA + lipid bilayer; MHA + 
lipid bilayer + 1 μM TAT (44-57); and MHA + lipid bilayer + 10 
μM TAT (44-57). For comparison, theoretical approach curves 
for a pure insulator and a pure conductor are also 
presented.[24a] Using this SECM method, the ultra-
microelectrode (UME) is made to approach the surface at a 
constant rate while oxidizing ferrocyanide ([Fe(CN)6]4-) at a 
diffusion-limited rate. The current (itip) is measured during this 
approach and the data then normalized by plotting itip/ibulk 
versus d/a where ibulk is the diffusion-limited current measured 
at the tip when it is far away from the surface, a is the tip radius 
and d is the tip-sample distance. Therefore, any increase in the 
value of itip/ibulk over that of the insulator approach curve 
indicates that the oxidized form, ferricyanide ([Fe(CN)6]3-) is 
converted back to ferrocyanide at the gold electrode surface, 
thereby resulting in a positive feedback effect. For this to occur, 
electron transfer between the redox mediator and the 
underlying gold electrode needs to occur, as neither the MHA 
layer nor the lipid bilayers investigated in this study can 
facilitate reduction of the oxidized mediator. 
 
Figure 3. SECM data for the TAT (44-57) peptide interaction with 
bacterial (PC:PG) and mammalian (PCc) mimetic membranes. SECM 
approach curves for the study of the interaction of TAT peptide on different 
regions of the SLBs deposited ex-situ. A comparison of the current feedback 
measured upon exposure of the PC:PG and PCc membranes to the same 
peptide concentration, reveals the much more dramatic and selective effect 
of TAT on PC:PG membrane is evident. These data are plotted as a 
normalised range of data (values measured for the feedback current). The 
experiments were carried out on unbiased substrates and the potential of the 
Pt UME (25 μm diameter) was held at 0.4 V (a Pt wire counter and Ag/AgCl 
reference electrode were used to complete the electrochemical cell). An 
approach speed of 1 μm/s was used in an electrolyte consisting of 1 mM 
K4[Fe(CN)6] in PBS buffer. 
                              
As expected, the MHA significantly inhibits the electron 
transfer from the gold surface to the redox mediator [Fe(CN)6]4- 
(Figure 3b), in accord with previous studies for SAMs on gold 
electrodes.[25] The formation of both types of lipid bilayer on the 
MHA layer (PC:PG (2:1) and PCc (7:3)) further decreased the 
normalized current to values closer to that of a pure insulating 
surface, indicating that the permeability of the biomimetic 
membrane to the ferricyanide mediator is very low. This is 
consistent with the earlier results of Tsionsky and co-
workers.[26] 
 
Significantly, the addition of TAT (44-57) increased the 
permeability of the membrane, as evidenced by the increase in 
feedback current (Figure 3b) and indicates that this particular 
peptide is capable of creating pathways via which the redox 
mediator can be re-generated. It should be noted that the data 
is represented by a range of different approach curves 
measured at different regions on the same QCM sensor, as 
indicated by the shaded areas in Figure 3. This indicates that 
the interaction of TAT with the membrane is not homogeneous 
on the micron scale. Therefore, the three possible mechanisms 
espoused to explain the QCM-D data could be narrowed down 
to one using the SECM results: pore formation. Neither surface 
association nor direct translocation would increase membrane 
permeability. A concentration dependence is observed in both 
cases, whereby increasing the TAT concentration to 10 µM 
results in further permeation of the membrane by the redox 
species. Perhaps most significantly, however, the composition 
of the lipid bilayer plays a crucial role and significantly 
influences the magnitude of the feedback current. In the case 
of DMPC:DMPG (2:1), the QCM-D data indicates disruption of 
the membrane. This disruption corresponds to a broad range 
of data with higher feedback current in the SECM 
measurements (green band (1.0 µM) and mauve band (10 µM) 
in Figure 3a) with the high variance indicating loss of 
membrane integrity. The SECM response observed upon 
exposure of PCc to TAT (44-57) is dramatically different, with 
tight bands of increased feedback current data observed (i.e. 
small error bars) that are consistent with a much less disruptive 
mechanism of membrane interaction, namely worm-hole pore 
formation.  
 
Worm-hole formation observed by AFM. Having 
determined that TAT (44-57) acts on PCc bilayers via a pore 
mechanism, AFM was then used to investigate the nanoscale 
structure of the peptide-membrane layer. The AFM 
measurements used single crystalline facets of gold on a gold 
bead electrode. The high mobility of peptides in model 
membranes, combined with the transience of peptide pores, 
makes it difficult to image these structures in solution.[16, 21, 27] 
Thus, in an attempt to trap the pore assemblies, the samples 
were carefully dried under a stream of N2 immediately prior to 
imaging. This involved some trial-and-error to ensure that the 
lipid head groups were not completely dehydrated (which can 
cause membrane defects) while removing the bulk solution. 
The membrane surface in Figure 4 shows no drying-induced 
defects on the PCc layer. Additional AFM images are displayed 
in Figure S4. 
 
The thickness of the membranes was determined to be ~5 
nm by punching holes in the membranes with the AFM tip, with 
a depth close to that expected for a PCc bilayer.[28] 
Furthermore, the lipid domains (possibly cholesterol-rich) did 
not move or change over time, suggesting that drying had 
reduced lipid mobility. Upon the addition of a 10 µM solution of 
TAT (44-57), a small number of discrete pores were observed 
on the bilayer surface (Figure 4). These pores were less than 1 
nm in depth (generally ~ 0.5 nm, although some were smaller), 
as shown in two cross-sectional regions (Figure 4 (i and ii)) 
and hence not trans-membrane in nature. It is possible, 
however, that the removal of water partially collapsed the 
pores. The pores were found to cover ca. 0.58% of the 
membrane surface. This low coverage is consistent with the 
SECM results, which showed that after saturation with TAT 
(44-57), the membrane permeability increased only slightly, as 
evidenced by the feedback current (Figure 3b). 
Interestingly, our data agree well with the most recent 
biophysical studies[13] that supports the formation of a 
“contiguous transbilayer water channel” consistent with a 
‘worm-hole’ pore. Their study[13] however used an 80:20 ratio of 
PC:PG which lies between the lipid ratio’s that we used here, 
these data are consistent with our findings.  
 
Figure 4. AFM height image and cross-sectional analysis of worm-hole 
pores. Morphology of a MHA-modified gold bead covered with a membrane 
(PCc) bilayer, 20 mins after addition of 10 µM TAT (44-57); vertical scale is 
0-1.5 nm. The membrane surface is punctuated with small pores. Cross 
sectional analyses across the two regions (i and ii) are highlighted, revealing 
that these pores are ~0.5 nm deep. The AFM images of the bilayer taken 
before the addition of the peptide and additional AFM images are found in 
Figure S4. 
Computational analysis was used to estimate the TAT (44-
57) peptide dimensions based on α-helical secondary structure 
is shown in Supplementary Information (Figure S5). The 
energy minimised α-helical representation gave the estimated 
length of 2.1 nm compared with the extended peptide that gave 
a length of 4.8 nm. 
Figure 5 summarises the application of three ‘spatially-
resolved’ techniques with very different, but complementary, 
analytical powers, which has accumulated strong evidence for 
worm-hole pore formation upon exposure of a mammalian-
mimetic membrane to TAT peptides. The QCM data for the 
PPc membrane reveal saturation of the membrane (~-5 ± 2 Hz), 
with increased concentration of the TAT peptide causing a 
stiffening of the membrane, whilest more pronounced 
disruption (loss of membrane and peptide) occurs for the 
bacterial-mimetic (PC:PG) membrane. Although the QCM 
sensor provides an ‘average’ large-scale measurement (~0.8 
cm2 resolution), the similar response observed in all the 
harmonics upon exposure of the PCc membrane to the 
peptides is indicative of trans-membrane insertion. The AFM 
images support this model, revealing worm-hole pores across 
the membrane at various depths. The approach curves from 
the SECM analyses provide extremely valuable information 
about the permeability of these worm-hole pore structures, by 
          
measurement of the accessability of a redox mediator to 
traverse the cross-sectional axis of the membrane bilayer 
(albeit prior to membrane disruption for the PC:PG bilayer). 
Our experimental design provided the ability to probe the same 
surface with the QCM and SECM measurements (although the 
QCM was undertaken at least 30 minutes before the SECM 
measurements in all cases), thus it is difficult to reconcile the 
observed effects as micron scale-detection in the case of 
SECM measrements. 
In summary, the QCM, SECM and AFM data were all found 
to be in accord with the TAT (44-57) peptide spontaneously 
forming ‘worm-hole’ pores within the mammalian-mimetic lipid 
bilayers. Furthermore, we showed that the shorter TAT (49-57) 
peptide (Ac-R50KKRRQR55RR-NH2) behaved similarly towards 
these biomimetic membranes (see Supplementary Information).  
 
Figure 5. Illustration of the combination of techniques that, in concert, 
provide evidence for the formation of a worm-hole pore by TAT in a 
PCc membrane layer.  The three scales of measurement used in this study 
combine to support a worm-hole mechanism: A QCM shows TAT binding in 
a transmembrane manner (mm resoution), B the UME probes membrane 
permeability with the the redox mediator [Fe(CN)6]4-/3- (R/O) revealing a 
greater feedback current due to the pore formation at the 25 µm (electrode 
diameter) resolution and C AFM reveals punctures within the PCc 
membrane due to the addition of TAT peptide, penetrating approximately 0.5 
nm into the lipid bilayer (nm level resolution). 
Conclusions 
In conclusion, the combination of three techniques (QCM, 
SECM, AFM) provided scales of measurement from millimetre 
to nanometre and reveal a consistent mechansim for the 
uptake of TAT peptides by mammalian-mimetic membranes, 
through the formation of ‘worm-hole’ pores. Pore formation can 
occur spontaneously, with membrane saturation occurring at 
low concentrations (≤1.0µM) and only a small number of worm-
hole pores existing at any instant, explaining the low hemolytic 
activity of TAT. Additional data using SECM supported the lytic 
mechansim towards the bacterial-mimetic (PC:PG) membrane, 
supporting our previous work.15 Although questions remain 
unanswered as to the nature of peptide aggregation 
(stoichiometry) prior to and during translocation these results 
place us a step closer to fully comprehending the elusive 
mechansim of translocation of the TAT peptide and possibly 
related arginine-rich peptides. These findings together with 
structural flexibility31 considerations determined using cyclic 
TAT peptides reinforce the development of cell-penetrating 
peptide-based technologies for future applications. The ‘worm-
hole’ pores formed by the TAT peptide translocation are 
transmembrane and explain the ability of the TAT-conjugated 
cargoes to specifically traverse cellular mammalian 
membranes. Future applications of the TAT peptide or related 
cell-penetrating peptides for the intracellular delivery of 
therapeutics can now be designed with ‘tuneable’ specificity 




TAT (44–57) and TAT (49–57) with N-terminal acetylation and 
C-terminal amidation were synthesised with L-amino acids by 
automated solid phase peptide synthesis on a Rink amide 
resin. 
Buffer preparation 
Sodium chloride (≥99.5%), potassium phosphate monobasic 
(anhydrous, ≥99.0%) and potassium phosphate dibasic 
(anhydrous, ≥98%) were purchased from Sigma-Aldrich 
(Castle Hill, Australia). Ultrapure water was used with an initial 
resistivity of 18.2 MΩ·cm (Sartorius AG, Göttingen, Germany). 
Phosphate buffered saline (PBS, pH 6.9±0.1) was prepared 
having 20 mM phosphate and either 100 mM or 30 mM sodium 
chloride (NaCl) in water. 
Liposome preparation 
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium salt) 
(DMPG) were purchased from Avanti Polar Lipids (Alabaster, 
USA). Cholesterol, chloroform (≥99.8%) and methanol 
(≥99.9%) were purchased from Sigma-Aldrich (Castle Hill, 
Australia). DMPC and cholesterol were dissolved in chloroform 
whereas DMPG was dissolved in chloroform/methanol (ca. 3:1) 
to create individual 5 mM stock solutions. These solutions were 
then aliquoted into test tubes to obtain the desired lipid 
composition (DMPC:cholesterol 7:3 v/v, and DMPC:DMPG 2:1 
v/v). Afterward, the solvent was evaporated under a gentle 
stream of nitrogen gas and the test tubes were then dried 
under vacuum. To prepare the liposomes, the lipids were re-
suspended in PBS (NaCl, 100 mM) to a lipid concentration of 
0.5 mM and then incubated at 37 °C, vortexed and sonicated 
for less than 10 minutes in a bath sonicator before use. We 
have demonstrated that the liposomes, obtained with this 
protocol, are unilamellar and have a bimodal size distribution, 
with the radii of the two populations on average ca. 50 and 300 
nm [23b]. 
Modification of QCM-D sensor chips 
Absolute ethanol (≥99.7%), propan-2-ol (≥99.0%) and 
hydrogen peroxide (30%) were purchased from Merck (Kilsyth, 
Australia). Ammonium hydroxide solution (28%) was obtained 
from Ajax Finechem (Seven Hills, Australia). 6-
mercaptohexanoic acid (MHA, 90%) was purchased from 
Sigma-Aldrich (Castle Hill, Australia). The QCM-D sensor 
crystals used were polished, gold-coated, AT-cut quartz chips 
with a fundamental frequency of ca. 5 MHz (Q-Sense, Västra 
Frölunda, Sweden). At least 24 hours before an experiment, 
the chips were cleaned in a solution of ammonium hydroxide: 
hydrogen peroxide: ultrapure water (1:1:3 v/v) for 20–25 min at 
ca. 70 °C. The chips were then rinsed thoroughly with ultrapure 
water. Surface modification with MHA was conducted by 
immersing a freshly cleaned chip into a 1.0 mM solution of 
MHA in propan-2-ol for at least 24 h. This creates a self-
assembled monolayer of uniform negative charge on the chip 
                              
surface. Excess MHA was removed by rinsing with propan-2-ol. 
The chips were then dried under a gentle stream of nitrogen 
gas and assembled into the QCM-D chambers ready for use. 
QCM-D experiments 
QCM-D measurements were performed using a Q-SENSE E4 
system with flow cells (Q-SENSE, Västra Frölunda, Sweden). 
The QCM-D instrument measures the relative changes to the 
resonance frequency (f) and energy dissipation (D) of a sensor 
chip. The natural frequency of this gold-coated chip is a 
function of the overall mass in the oscillating system, which 
consists of the mass of the sensor chip as well as the mass of 
the material deposited on the surface. During the experiment, 
the difference in resonance frequency (∆f) and energy 
dissipation (∆D) were measured simultaneously at four odd 
overtones of the natural frequency (3rd overtone at 15 MHz, 5th 
overtone at 25 MHz, 7th overtone at 35 MHz, and 9th overtone 
at 45 MHz). The fundamental resonance frequency has not 
been considered because of its high sensitivity to the bulk 
solution changes. All experiments were conducted at a 
temperature of 19.10 ± 0.05 °C and repeated at least three 
times. 
In a typical experiment, firstly, supported membranes were 
created on a chip surface modified with a MHA monolayer 
through a slow flush of liposome solution in the QCM 
chambers at a 50 µL/min flow rate. The liposomes adsorb onto 
the MHA-monolayer, deform, rupture and fuse together to form 
a lipid bilayer.[23b] The flow was then stopped, and then PBS 
solution (100 mM NaCl) was flushed in the cell at a 300 µL/min 
to eliminate any weakly attached liposomes. In addition, a flow 
with PBS buffer (30 mM NaCl), at the same speed, was 
adopted to help any burst of embedded liposomes. This 
second washing step was introduced to ensure the formation 
of a homogeneous membrane and works by creating an 
osmotic pressure difference between the interior of the 
embedded liposomes (having a high salt concentration) and 
the low-salt exterior environment, which causes the liposomes 
to swell and then rupture. Once a stable lipid membrane was 
obtained, the next step was flushing 1 mL of peptide solution (1 
and 10 μM in PBS) in the cell at a 50 µL/min flow rate. After the 
flow was stopped, the system was left for a minimum of 30 
minutes to equilibrate, before rinsing with PBS buffer at 200 
µL/min. After the flow was stopped, the peptide was left to 
incubate with the lipid membrane for 30 min and then the 
chamber was rinsed with high-salt PBS. Data were recorded 
as frequency change corresponding to a change in mass of the 
sensor chips. The value of this mass was calculated by using 
the Sauerbrey equation:[29] 
∆m = -(∆f/n) C 
where C (17.7 ng∙cm -2∙Hz -1 at 5 MHz) is the mass sensitivity 
constant, and n (1, 2, 3… ) is the overtone number. Cho and 
co-workers have demonstrated that the Sauerbrey equation 
efficiently models lipid bilayers in aqueous buffer.[30] 
Furthermore, the structural changes of the deposited layers 
were revealed by measuring the ratio of energy loss to energy 
stored (dissipation, D) into the surface bound material.[31] 
The raw data resulting from every experiment has been 
processed using QTools (Q-SENSE), and then exported for 
advanced analysis in OriginPro 8 (OriginLab Corp., 
Northampton, MA, USA) software. 
SECM experiments 
The current feedback experiments were carried out at 
unbiased substrate in 1.0 mM K4[Fe(CN)6] in PBS, as a 
mediator, using a 25μm Pt ultra-microelectrode (UME), 
Ag/AgCl and a Pt wire as working, reference and counter 
electrodes, respectively. Prior to measurements, the QCM 
sensor was pre-modified through treatment with 6-
mercaptohexanoic acid (MHA) solution overnight, then washed 
with iso-propanol to eliminate loosely-bound and excess MHA 
from the surface, and dried under a gentle stream of nitrogen. 
MHA was chosen as its chain length is sufficient to form an 
insulating self assembled monolayer (SAM) on the sensor’s 
gold surface. In order to ensure the formation of the MHA layer 
on the gold, the sensor was then placed in the mediator 
solution, followed by probing the conductivity of three different 
spots on the sensor by biasing the UME at 0.4 V and 
approaching the surface at 1 μm/s. The QCM sensor was 
taken out of the mediator solution after measurements and 
rinsed with PBS buffer several times. This was followed by 
adding the lipid suspension onto the MHA-modified sensor and 
leaving to incubate for 30 minutes in order to form a supported 
lipid bilayer (SLB) on the MHA. The QCM sensor was then 
placed back into the mediator solution and the conductivity was 
probed as previously explained. Subsequently, 1.0 and 10 μM 
TAT-treated membrane samples were probed in a similar 
manner, although with an incubation time of 10 minutes. 
AFM  
The substrate for AFM measurements was a gold bead 
prepared by melting the end of a gold wire (diameter 1.2 mm, 
purity 99.99%, Goodfellow,UK) in a hydrogen-oxygen flame.[32] 
Several small Au(111) facets (approximately 0.5-1.0 mm long) 
would appear on the well-prepared gold bead surface and 
could be observed with the unaided eye. These small facets 
were of atomic flatness and served as the AFM substrate. The 
gold bead that contained crystalline facets was freshly 
prepared and this bead was immediately plunged into an 
ethanolic solution of MHA to form a self-assembled monolayer. 
The membrane coating was achieved by immersion in a 
suspension of DMPC:cholesterol hydrated with buffer 
(prepared as described for the QCM-D measurements). 
Following rinsing with buffer and water, the bead was dried 
under a stream of nitrogen gas, to remove the macroscopic 
water, but not to complete dryness. The resulting membrane 
patches were identified on the crystalline ‘triangular’ features 
on the Au(111) facets of the bead. Cholesterol-rich regions 
were evident within the membrane structure. No particular 
specificity was observed for the TAT peptide towards 
cholesterol-rich or -poor domains. 
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How does the TAT peptide 
translocate across a mammalian 
cell membrane? Three biophysical 
methods, which can spatially 
resolve scales from millimetre 
(QCM-D); micrometre (SECM) to 
nanometre (AFM), provide 
evidence for ‘wormhole’-like pores. 
SECM showed these pores allow 
redox mediators to pass through to 
the sensor. However, TAT disrupts 
bacterial-mimetic membranes.    
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